Evidence map›Paper›PMID 30945455›Full record

ArticleFEBS open bio2019

Panax notoginseng saponins alleviate skeletal muscle insulin resistance by regulating the IRS1-PI3K-AKT signaling pathway and GLUT4 expression.

Xuan Guo, Wen Sun, Guangbin Luo, Lili Wu, Guangyuan Xu, Dan Hou, Yi Hou, Xiangyu Guo, Xiaohong Mu, Lingling Qin and 1 more

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The application ofAnnals of translational medicine · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Role ofInternational journal of molecular sciences · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Xuan GuoDongfang Hospital of Beijing University of Chinese Medicine, China.
Wen SunKey Laboratory of Health Cultivation of the Ministry of Education, Beijing University of Chinese Medicine, China.
Guangbin LuoSchool of Life Sciences, Beijing University of Chinese Medicine, China.
Lili WuKey Laboratory of Health Cultivation of the Ministry of Education, Beijing University of Chinese Medicine, China.
Guangyuan XuDepartment of Traditional Chinese Medicine, Fu Xing Hospital of Capital Medical University, Beijing, China.
Dan HouKey Laboratory of Health Cultivation of the Ministry of Education, Beijing University of Chinese Medicine, China.
Yi HouDongfang Hospital of Beijing University of Chinese Medicine, China.
Xiangyu GuoDongfang Hospital of Beijing University of Chinese Medicine, China.
Xiaohong MuDepartment of Orthopaedics, Dongzhimen Hospital of Beijing University of Chinese Medicine, China.
Lingling QinScience and Technology Department, Beijing University of Chinese Medicine, China.
Tonghua LiuDongfang Hospital of Beijing University of Chinese Medicine, China.
Beijing University of Chinese Medicine · CNCapital Medical University · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Panax notoginseng saponins (PNS) are a commonly used traditional medicine to treat diabetes in China. Recent studies have confirmed their anti-diabetic effects, but the underlying mechanisms have remained unclear. The present study was designed to explore whether PNS decrease hyperglycemia by improving insulin sensitivity in skeletal muscle and to elucidate the molecular mechanisms. The anti-diabetic effects of PNS were analyzed in a skeletal myoblast cell line, C2C12, and in high fat diet-induced diabetic KKAy mice. C2C12 cells were treated with PNS (50, 100, and 200 μg·L

Indexed as

AnimalsCell LineDiabetes Mellitus, ExperimentalGlucose Transporter Type 4Insulin ResistanceMaleMiceMice, Inbred C57BLMuscle, SkeletalPanax notoginsengRandom AllocationSaponinsSignal TransductionGlucose Transporter Type 4SaponinsSlc2a4 protein, mousediabetesGLUT4IRS1-PI3K-AKT signalingKKAy micePanax notoginseng saponinsskeletal muscle

Identifiers

PMID30945455
PMCPMC6487711
OpenAlexW2925891904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.